Introduction
Cytokine-induced killer (CIK) cells have recently been shown to be highly effective in targeting viruses to tumor target cells [1] . CIK cells consist of a heterogeneous population of effector cells after stimulation with a mixture of interferon-gamma (IFN-γ), anti-CD3 (αCD3), interleukin-2 (IL-2) and interleukin-1beta (IL1β). CIK cells possess a cytolytic activity while it is stated that their killing is nonmajor histocompatibility complex (MHC)-restricted [2] , [3] . This makes them different from normal cytotoxic T lymphocytes (CTL) as these need MHC molecules on antigen presenting cells (APCs) which presents antigenic peptides to the T cell receptor (TCR) on CTL. The major cytotoxic subset of the CIK cells are CD3 + and CD56 + , which will be the most important property to identify these cells by fluorescence activated cell sorting (FACS) in this work. This NKT cell like subset derives from cytotoxic T lymphocytes [4] . Natural killer T (NKT) cells form a subpopulation of T cells with interesting properties. NKT cells express both natural killer (NK) cell markers, like CD56, as well as T cell markers, like CD3. NKT cells are believed to play crucial roles in several diseases, inhibiting one and exacerbating another. Amongst others it is stated [5] that NKT cells inhibit diabetes and several infectious diseases while they exacerbate allergic asthma, lupus and atherosclerosis. The most important fact to know about NKT cells is their special α/β T cell receptor. There are two types of NKT cells: Most of them express an invariant TCR while some do not. The first are called type I NKT cells and the latter type II NKT cells. Usually type I NKT cells are referred to as NKT cells. The invariant TCR of these human cells is composed of the Vα24-JαQ α-chain and one of several β-chains, but mainly Vβ11. This TCR does not recognize peptide antigens like the α/β TCR of a normal CTL, but instead glycolipid antigens presented by the nonclassical MHC molecule CD1d on APCs. Because it is assumed that the physiologically recognized antigens are endogenous, it is believed that the NKT cells are autoreactive: Upon stimulation, the APCs present the proper endogenous antigen to the TCR of the NKT cells and thus activate those cells. As stated in literature it is not possible to stimulate NKT cells without CD1d expressing cells [6] . NKT [7] . Type II NKT cells are different from type I in that they do not express the invariant Vα24 TCR but a diverse TCR and do not respond to the stimulator of type I NKT cells KRN7000. But still these cells respond to other lipid antigens presented to them by CD1d on APCs. The functions and antigens of type II NKT cells seem to differ, as some of these cells are autoreactive. Thus the type II NKT cells are no homologous population of cells [8] , [9] . For stimulation of NKT cells two glycosphingolipids were used. As mentioned before, these antigens are presented to the NKT cells by the molecule CD1d on certain APCs. This happens in a way that the glycosphingolipid is bound with its lipid part to the hydrophobic groove of CD1d while the carbohydrate portion interacts with the TCR of the NKT cell. KRN7000 was the first substance used. This glycosphingolipid is an exogenous stimulator for NKT cells which was originally isolated from a marine sponge. Because it is stated to activate NKT very strongly, this substance was used as positive control. Additionally we used the glycosphingolipid globotrihexosylceramide-3 (Gb3). In contrast to KRN7000 this glycosphingolipid has no stimulating effect on NKT cells and was used as negative control. CIK cells were assumed to be part of this type I NKT cell population, but this was not yet investigated.
Material and methods

Isolation of peripheral blood leukocytes
Blood from buffy coats was mixed 1:2 with PBS/1%BSA (both PAA, Cölbe, Germany) and used for a ficoll gradient (LymphoPrep, PAA, Cölbe, Germany). After the centrifugation at 800 g for 30 minutes, the leukocyte layer was removed and collected in new tubes. These cells were then washed 3 times with PBS/1%BSA and afterwards resuspended in fresh medium, consisting of RPMI medium (PAA, Cölbe, Germany) with 10% fetal calf serum (Invitrogen, Karlsruhe, Germany), 2.5% hepes buffer solution (PAA, Cölbe, Germany) and 1% penicillin/streptomycin (PAA, Cölbe, Germany). An adhesion period of 1 hour was performed in a culture flask and the non-adherent cells were removed and used for culture subsequently.
Generation of cytokine-induced killer cells
The non-adherent cell population from blood was cultured in complete RPMI medium at a density of 2-3 x 10 6 cells mL -1 . The CIK culture was generated as previously described [10] but with minor changes: At the day of isolation IFN-γ was added in a final concentration of 1000 U mL -1 medium. On day 1 of the culture, anti-CD3 (Cilag GmbH, Sulzbach, Germany) and IL1β (Boehringer Mannheim Biochemica, Mannheim, Germany) were added, resulting in a final concentration of 100 ng mL -1 anti-CD3 (instead of 50 ng mL -1 as stated in literature) and 100 U mL -1 IL1β in the culture. On the days 1, 3, 6, 9 and 12 the CIK culture was supplemented with 300 U mL -1 IL-2. Additionally fractions of the culture were removed on these days and fresh medium was added.
Stimulation of type I natural killer T cells
To the αGalCer culture 100 ng mL -1 αGalCer (KRN7000; Kirin brewery, Gunma, Japan) in methanol were added at the day of isolation. To the negative control, the Gb3 culture, 100 ng mL -1 Gb3 (Alexis, Lausen, Switzerland) were added at the day of isolation. The working solution of Gb3 had the same concentration as the KRN7000 working solution and was also dissolved in methanol. To both cultures 300 U mL -1 IL-2 were added on the days 1, 3, 6, 9 and 12. Additionally fractions of the culture were removed on these days and fresh medium was added. The cultures will be named by the type of their initial stimulus through out this work, i.e. CIK, KRN7000 and Gb3 as is shown in Table 1 .
Analysis of cell surface markers
Cells from the different cultures were counted and analysed in flow cytometry with fluorescein isothiocyanate (FITC) labelled antibody and/or phycoerythrin (PE) labelled antibody against various surface markers. The following labelled antibodies from Coulter Immunotech were used: CD3 PE and CD8 FITC, CD14 FITC, CD19 FITC, Vα24 FITC and the isotype controls IgG1 mouse FITC and IgG1 mouse PE, as well as the antibodies from BD Pharmingen: CD3 FITC, CD4 FITC and CD56 PE. The measurement was done with an Epics XL-MCL System II Version 3.0 Instrument (Coulter Immunotech, Krefeld, Germany). For each measurement, data from 20,000 cells was collected. The negative controls were set to 1.0%-2.0% using the isotype controls. 
Results
The results from the flow cytrometric analysis (Figure 1 
Discussion
As described above, we were able to characterise the different subpopulations in each culture. The CIK culture as shown in Figure 1 was composed almost entirely of CD3 + cells (~99%). The mean percentage of CD56 + cells in the CIK culture was 17.5% +/-3.5%. CD3 + /CD56 + cells, which are the classical effector cells of the CIK population [3] , reach up to 14% of the CIK culture. Earlier we could show that NKT cells are the major cytotoxic subset of the CIK cells [11] . All of the cells in the CIK culture were ) was also present in this culture while these populations were smaller than in the KRN7000 culture. This culture was negative for Vα24 and thus did not include any type I NKT cells.
Conclusions
In conclusion, without the expression of Vα24 on CIK cells, these cells can not be assumed to be normal NKT cells, in this context type I NKT cells. But it may be possible that the CIK cells belong to the type II NKT cells which possess different properties than the type I NKT cells. This has to be investigated based on the CD1d reactivity of the CIK cells, because both types of NKT cells are reactive to the antigen presenting molecule CD1d [8] , [9] .
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